Roche Holding AG (OTCMKTS:RHHBY) Short Interest Update

Roche Holding AG (OTCMKTS:RHHBY) saw a large growth in short interest in October. As of October 15th, there was short interest totalling 3,246,800 shares, a growth of 25.2% from the September 30th total of 2,593,100 shares. Based on an average daily volume of 2,151,600 shares, the short-interest ratio is currently 1.5 days.

Roche Price Performance

OTCMKTS:RHHBY traded down $0.39 during mid-day trading on Wednesday, hitting $39.46. 831,027 shares of the company’s stock traded hands, compared to its average volume of 2,155,573. The firm has a 50 day moving average of $39.88 and a two-hundred day moving average of $36.48. Roche has a 12 month low of $29.20 and a 12 month high of $42.43.

Analyst Upgrades and Downgrades

RHHBY has been the subject of a number of recent research reports. Bank of America upgraded shares of Roche from a “neutral” rating to a “buy” rating in a report on Friday, September 13th. Deutsche Bank Aktiengesellschaft cut Roche from a “hold” rating to a “sell” rating in a research report on Friday, September 13th. Three analysts have rated the stock with a sell rating, one has issued a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold”.

Institutional Investors Weigh In On Roche

Hedge funds and other institutional investors have recently modified their holdings of the stock. AlphaMark Advisors LLC bought a new position in shares of Roche during the 1st quarter worth about $34,000. GAMMA Investing LLC lifted its position in shares of Roche by 61.5% in the 2nd quarter. GAMMA Investing LLC now owns 5,038 shares of the company’s stock worth $175,000 after acquiring an additional 1,919 shares during the period. Archer Investment Corp grew its holdings in shares of Roche by 10.6% during the 2nd quarter. Archer Investment Corp now owns 6,810 shares of the company’s stock worth $236,000 after purchasing an additional 652 shares in the last quarter. Waldron Private Wealth LLC acquired a new stake in Roche during the second quarter worth $263,000. Finally, Lee Danner & Bass Inc. acquired a new position in shares of Roche in the 2nd quarter valued at $327,000.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.